论文部分内容阅读
为了探讨安尔康癌症尿检试剂对肺癌诊断价值，检查了３０例肺癌患者和２０例良性肺病患者，阳性率为８３％，假阳性率为１０％，同时检查了ＣＥＡ、肺癌组血清ＣＥＡ水平为８．２０±７．６５μｇ·Ｌ－１、良性肺病组为３．１４±２．８μｇ·Ｌ－１，有显著性差异（Ｐ＜０．０１），ＣＥＡ和ＡＵＴＲＣＳ的敏感性分别为５３％、８３％（Ｐ＜０．０２５）。差异有显著性，但是特异性分别为７５％、８０％，无显著性差异，因此，我们认为ＡＵＴＲＣＳ操作是简单、方便、快速和价廉，它的临床价值高于ＣＥＡ，可作为肺癌诊断和随仿的辅助检查。
In order to investigate the diagnostic value of Aner Kang’s cancer urine test reagents for lung cancer, 30 lung cancer patients and 20 benign lung diseases patients were examined. The positive rate was 83%, and the false positive rate was 10%. Serum CEA levels in CEA and lung cancer patients were also examined. 8.20±7.65μg·L-1, benign lung disease group was 3.14±2.8μg·L-1, with significant difference (P<0.01). The sensitivity of CEA and AUTRCS was 53% respectively. , 83% (P < 0.025). The differences were significant, but the specificities were 75% and 80%, respectively, and there was no significant difference. Therefore, we believe that the operation of the AUTCS is simple, convenient, fast, and inexpensive. Its clinical value is higher than that of the CEA and can be used as a diagnosis of lung cancer. Followed by the auxiliary inspection.